Publications and communications of Jeremy Blavier

Puttemans, J.* , Brammerloo, Y.* , Blibek, K., Blavier, J., Ntombela, T., Van Molle, I., Joseph, J., Olivet, J., Saha, D., Degey, M., Hamaïdia, M., Jain, P., Geraldine, P., Zimmermann, P., Kim, D.-K., Baiwir, D., Njock, M.-S., Dequiedt, F., Salehi-Ashtiani, K., ... Maseko, S. B.*. (August 2025). Inhibitors of Tax1-PDZ Interactions Block HTLV-1 Viral Transmission by Changing EV Composition. Journal of Extracellular Vesicles, 14 (8), 70137. doi:10.1002/jev2.70137
* These authors have contributed equally to this work.

Venit, T.* , Blavier, J.* , Maseko, S. B.* , Shu, S., Espada, L., Breunig, C., Holthoff, H.-P., Desbordes, S. C., Lohse, M., Esposito, G., Twizere, J.-C.* , & Percipalle, P.*. (2024). Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia. Molecular Therapy: Nucleic Acids, 102304. doi:10.1016/j.omtn.2024.102304
* These authors have contributed equally to this work.

Trepte, P.* , Secker, C.* , Olivet, J.* , Blavier, J.* , Kostova, S., Maseko, S. B., Minia, I., Silva Ramos, E., Cassonnet, P., Golusik, S., Zenkner, M., Beetz, S., Liebich, M. J., Scharek, N., Schütz, A., Sperling, M., Lisurek, M., Wang, Y., Spirohn, K., ... Wanker, E. E.*. (April 2024). AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor. Molecular Systems Biology, 20 (4), 428 - 457. doi:10.1038/s44320-024-00019-8
* These authors have contributed equally to this work.

Maseko, S. B., Brammerloo, Y., Van Molle, I., Sogues, A., Martin, C., Gorgulla, C., Plant, E., Olivet, J., Blavier, J., Ntombela, T., Delvigne, F., Arthanari, H., El Hajj, H., Bazarbachi, A., Van Lint, C., Salehi-Ashtiani, K., Remaut, H., Ballet, S., Volkov, A. N., & Twizere, J.-C. (21 July 2023). Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction. Antiviral Research, 217, 105675. doi:10.1016/j.antiviral.2023.105675

Blavier, J. (2022). Towards new drugs for immunotherapy in cancer [Poster presentation]. 2022 Télévie seminar, Liège, Belgium.

Pillaiyar, T., Rosato, F., Wozniak, M., Blavier, J., Charles, M., Laschet, C., Kronenberger, T., Müller, C. E., & Hanson, J. (05 December 2021). Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27. European Journal of Medicinal Chemistry, 225, 113777. doi:10.1016/j.ejmech.2021.113777